MODE OF ACTION OF THE ANTITUMOR COMPOUND GIRODAZOLE (RP-49532A, NSC-627434)

被引：27

作者：

COLSON, G ^{[1
]}

RABAULT, B ^{[1
]}

LAVELLE, F ^{[1
]}

ZERIAL, A ^{[1
]}

机构：

[1] RHONE POULENC RORER,CTR RECH VITRY ALFORTVILLE,13 QUAI JULES GUESDE,F-94403 VITRY,FRANCE

来源：

BIOCHEMICAL PHARMACOLOGY | 1992年 / 43卷 / 08期

关键词：

D O I：

10.1016/0006-2952(92)90701-J

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Girodazole (RP 49532A) or 3-amino-1-[4-(2 amino-1H-imidazolyl]-propanol, 2HCl is an experimental antitumor compound which inhibits protein synthesis in cell cultures and in cell free systems. The compound has been evaluated for its capacity to inhibit specific assays of initiation. elongation and termination of protein synthesis. Girodazole inhibited the release of nascent peptides from polyribosomes in rabbit reticulocyte lysates indicating that the major effect of the compound is on the protein synthesis termination step.

引用

页码：1717 / 1723

页数：7

共 15 条

[11]

OTTENHEIJM HCJ, 1988, ANTI-CANCER DRUG DES, V2, P333

[12] GENE ORDER OF POLIOVIRUS CAPSID PROTEINS [J].

REKOSH, D .

JOURNAL OF VIROLOGY, 1972, 9 (03) :479-&

[13]

VRIJSEN R, 1986, J BIOL CHEM, V261, P505

[14] MECHANISM OF EUKARYOTIC PROTEIN-SYNTHESIS INHIBITION BY BRUSATOL [J].

WILLINGHAM, W ;

STAFFORD, EA ;

REYNOLDS, SH ;

CHANEY, SG ;

LEE, KH ;

OKANO, M ;

HALL, IH .

BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 654 (02) :169-174

[15] SUPERNATANT FACTOR INVOLVED IN INITIATION COMPLEX FORMATION WITH EUKARYOTIC RIBOSOMES [J].

ZASLOFF, M ;

OCHOA, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (12) :3059-&

← 1 2 →